Sign in

Michael F. Mahoney

President and Chief Executive Officer at BOSTON SCIENTIFIC
Board
Since November 2012
Age
59 years
Education
Holds a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University.
Tenure
Joined BSX in October 2011 as President, was promoted to President and Chief Executive Officer in November 2012, and appointed Chairman of the Board in May 2016.

Also at BOSTON SCIENTIFIC

DJB
Daniel J. Brennan
Executive Vice President and Chief Financial Officer
WC
Wendy Carruthers
Executive Vice President, Human Resources
ACB
Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific

About

At 59 years old , he has built an impressive foundation in business and leadership, underpinned by his studies in finance and administration. Holds a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University, which set the stage for a career marked by progressive responsibilities.

Beginning his career at General Electric Medical Systems, he quickly ascended through the ranks, later serving as President and CEO of Global Healthcare Exchange and holding key leadership roles at Johnson & Johnson. He joined BSX as President in October 2011 and was promoted to President and Chief Executive Officer in November 2012, before being appointed Chairman of the Board in May 2016.

Beyond his roles at BSX, he has also contributed significantly to the broader healthcare sector through board memberships with prominent companies and participation in non-profit activities. His leadership style, characterized by a focus on operational excellence and strategic vision, has been instrumental in steering the company through dynamic market challenges.

$BSX Performance Under Michael F. Mahoney

Past Roles

OrganizationRoleDate RangeDetails
Boston Scientific Corporation President, CEO, and Director Nov 2012 - May 2016 Transitioned to also assume Chairman role later
Boston Scientific Corporation President Oct 2011 - Nov 2012 Joined BSX as President
Johnson & Johnson Worldwide Chairman, Medical Devices and Diagnostics Division Jan 2011 - Sep 2011 Oversaw 50,000 employees and seven franchises
Johnson & Johnson Worldwide Group Chairman, DePuy Franchise Apr 2007 - Jan 2011 Managed the orthopedics and neurosciences business
Global Healthcare Exchange President and CEO Jan 2001 - Mar 2007 Led provider of supply chain solutions connecting hospitals, manufacturers, distributors, and GPOs
General Electric Medical Systems General Manager, Healthcare IT Business N/A Held various roles over 12 years, culminating in this position

External Roles

OrganizationRoleDate RangeDetails
CVS Health Corporation Board Member N/A Current board member
Boys & Girls Club of Boston Involved N/A Active involvement
Boston College CEO Club Chair of the Board of Governors N/A N/A
American Heart Association CEO Roundtable Member N/A N/A

Fixed Compensation

Data from  FY 2024
Component NameAmountPayment ScheduleAdditional Details
Base Salary$1,400,000 Annual 2024N/A
401(k) Plan Match$20,700 Annual 2024N/A
Term Life Insurance$4,902 Annual 2024N/A
Aircraft Usage$150,000 Annual 2024N/A
Financial Planning$13,650 Annual 2024N/A
Other Compensation (Miscellaneous)$4,142 Annual 2024N/A
Change in Pension Value and Nonqualified Deferred Compensation Earnings$291,666 Annual 2024N/A

Performance Compensation

Data from  FY 2024

Performance-Based RSUs

MetricValueUnit/Detail
rTSR Threshold16,444 RSUs
rTSR Target54,816 RSUs
rTSR Maximum109,632 RSUs
ONSG Threshold27,408 RSUs
ONSG Target54,816 RSUs
ONSG Maximum109,632 RSUs
Grant DateFebruary 12, 2024 Date
Grant Date Stock Price$64.99 per share
Grant Date Fair Value (each)$3,562,492 USD
Vesting Schedule3-year period ending December 31, 2026 N/A
Actual Performance200% of target N/A

Option Awards (Equity Incentive Plan)

MetricValueUnit/Detail
Grant DateFebruary 12, 2024 Date
Exercise Price$64.99 per share
Number of Options144,516 Options
Grant Date Fair Value$3,562,493 USD
Vesting Schedule4 equal annual installments N/A

Non-Equity Incentive Plan Compensation (Annual Bonus Plan)

MetricValueUnit/Detail
Target Annual Award$2,170,000 USD
Applicable Distribution Percentage150% Percentage
Individual Performance Modifier115% Percentage
Actual ABP Award$3,743,000 USD
Maximum Payout225% of target Percentage of Target

Grants of Plan-Based Awards - Equity Incentive Award 1

MetricValueUnit/Detail
Performance MetricsrTSR & ONSG RSUs metrics
rTSR Threshold16,444 Shares
rTSR Target54,816 Shares
rTSR Maximum109,632 Shares
Grant DateFebruary 12, 2024 Date
Grant Date Fair Value$7,124,984 USD (target ONSG performance-based RSUs)
Grant Date Stock Price$64.99 per share
Vesting Schedule4 equal annual installments N/A

Grants of Plan-Based Awards - Equity Incentive Award 2

MetricValueUnit/Detail
Performance MetricrTSR RSUs metric
Threshold27,408 Shares
Target54,816 Shares
Maximum109,632 Shares
Grant DateFebruary 12, 2024 Date
Date ApprovedFebruary 6, 2024 Date
Grant Date Fair Value$3,562,492 USD
Grant Date Stock Price$64.99 per share
Vesting Schedule4 equal annual installments N/A
Monte Carlo AssumptionsRisk-Free Rate: 4.23%, Measurement Period: 2.88 years N/A